CANDLE - A Study of Acute Health Effects of Exposure to Particles Generated by Candles
1 other identifier
interventional
17
1 country
1
Brief Summary
INTRODUCTION: Particle contamination is suggested to have substantial negative effects on health, with candles emitting huge amount of particles, thus being one of the largest contributors to indoor air pollution. Chronic low levels of exposure to indoor particles over time is an important risk factor for the health of the population as a whole and it becomes particularly important for vulnerable groups like people suffering from respiratory diseases such as asthma. AIM: In a randomized controlled cross-over trial the difference in health effects between two candles I) a standard candle and II) a low emission candle modified from the standard candle is studied.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2020
CompletedFirst Submitted
Initial submission to the registry
November 4, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedFirst Posted
Study publicly available on registry
April 29, 2021
CompletedApril 29, 2021
April 1, 2021
4 months
November 4, 2020
April 28, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Particles in Exhaled Air (Surfactant Protein A & Albumin)
PExA: Subjects performed repeated breath maneuvers allowing for airway closure and re-opening, and exhaled particles were optically counted and collected on a membrane using the PExA® instrument set-up
At baseline (0 hour), after exposure (5 hours), and the day after exposure (24 hours)
Secondary Outcomes (12)
Change in Lung Function (FEV1 & FVC)
At baseline (0 hour), after exposure (5 hours), and the day after exposure (24 hours)
Change in Fractional exhaled nitric oxide (FENO)
At baseline (0 hour), after exposure (5 hours), and the day after exposure (24 hours)
Change in white blood cells in Blood
At baseline (0 hour), after exposure (5 hours), and the day after exposure (24 hours)
Change in Endothelial Progenitor Cells (EPCs) in Blood
At baseline (0 hour), after exposure (5 hours), and the day after exposure (24 hours)
Change in inflammatory markers in Blood
At baseline (0 hour), after exposure (5 hours), and the day after exposure (24 hours)
- +7 more secondary outcomes
Study Arms (3)
Standard Stearin Candle
ACTIVE COMPARATORSeveral candles will be lit. We will be using realistic burning cycles i.e. burning candles which extinguish and new ones being lit.
Modified low emission candle
EXPERIMENTALSeveral candles will be lit. We will be using realistic burning cycles i.e. burning candles which extinguish and new ones being lit.
Clean Air
NO INTERVENTIONNo candles in the chamber.
Interventions
Burning candles will produce particulate air pollution being passed on an exposure chamber where the participants will be sitting for 5 hours.
Burning candles will produce particulate air pollution being passed on an exposure chamber where the participants will be sitting for 5 hours.
Eligibility Criteria
You may qualify if:
- Age 18-25
- Medically treated / physician diagnosed mild seasonal asthma GINA guidelines step 1 or 2 (https://ginasthma.org/)
- Never smoker or ex-smoker ≥ 6 months
- Allergy \> 1 common allergy
You may not qualify if:
- Any other disease that could influence the study parameters
- Conditions that prevent safe access to the climate chambers (such as claustrophobia)
- Perennial asthma
- Need for continuous medical treatment for asthma
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Aarhuslead
- Lund Universitycollaborator
- University of Copenhagencollaborator
- Danish Technological Institutecollaborator
- ASP-HOLMBLAD A/Scollaborator
- COOP Denmarkcollaborator
- Danwaxcollaborator
- Liljeholmens Stearinfabrikcollaborator
- Promolcollaborator
- European Candle Associationcollaborator
Study Sites (1)
Climate Chambers, Dept. Public Health, Aarhus University
Aarhus, Central Region Denmark, 8000, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Torben Sigsgaard, Prof.
University of Aarhus
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and medical doctor
Study Record Dates
First Submitted
November 4, 2020
First Posted
April 29, 2021
Study Start
September 1, 2020
Primary Completion
December 31, 2020
Study Completion
December 31, 2020
Last Updated
April 29, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share